ArticleCancer immunology research2018

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma.

Rana R McKay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.